Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women

Publish Year : 2016
Publisher : New England Journal of Medicine
Author Name : Nel A., van Niekerk N., Kapiga S., Bekker L.G., Gama C., Gill K., Kamali A., Kotze P., Louw C., Mabude Z., Miti N., Kusemererwa S., Tempelman H., Carstens H., Devlin B., Isaacs M., Malherbe M., Mans W., Nuttall J., Russell M., Ntshele S., Smit M., Solai L., Spence P., Steytler J., Windle K., Borremans M., Resseler S., Van Roey J., Parys W., Vangeneugden T., Van Baelen B., and Rosenberg Z.
Link : Click here

Description :

This article evaluates the safety and efficacy of a vaginal ring containing dapivirine for the prevention of HIV infection in nearly 2,000 women of reproductive age from South Africa and Uganda. The study was a randomized, double-blind, placebo-controlled trial and it found that the dapivirine ring was not associated with any safety concerns and was associated with a lower rate of HIV-1 infection than the placebo rate.

Recent Resource

Exploring Factors Associated with ART Adherence and Retention in Care under Option B+ Strategy in Malawi: A Qualitative Study

This qualitative study examines women's experiences with antiretroviral therapy (ART) adherence and...

Joint United Nations Statement on Ending Discrimination in Health Care Settings

The Joint Statement on Ending Discrimination in Health Care Settings, signed by twelve United...

Global Accelerated Action for the Health of Adolescents (AA-HA!): Guidance to Support Country Implementation

Adolescents are one sixth of the world's population and account for 6% of the world's global burden...

View More